Expertise in
6
conditions

Shengyu G. Zhou

Beijing Key Laboratory Of Key Technologies For Early Clinical Trial Evaluation Of Innovative Drugs For Major Diseases, Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Beijing, CN 
Expertise in
6
conditions
Beijing Key Laboratory Of Key Technologies For Early Clinical Trial Evaluation Of Innovative Drugs For Major Diseases, Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Beijing, CN 

Overview

Shengyu Zhou practices practicing medicine in Beijing, China.

Zhou is highly rated in 6 conditions, according to our data. Their clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Vertebroplasty.

They are actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 2 clinical trials.

Locations

Beijing Key Laboratory Of Key Technologies For Early Clinical Trial Evaluation Of Innovative Drugs For Major Diseases, Chinese Academy Of Medical Sciences & Peking Union Medical College, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Effect of RC108-ADC For Injection in Subjects With c-Met Positive Advanced Malignant Solid Tumors
A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Effect of RC108-ADC For Injection in Subjects With c-Met Positive Advanced Malignant Solid Tumors
Enrollment Status: Completed
Publish Date: January 06, 2026
Intervention Type: Drug
Study Phase: Phase 1
Study of Keynatinib in Patients With Advanced Non-small Cell Lung Cancer With Brain Metastasis or Progression of Brain Metastasis After Treatment With EGFR Inhibitor(s)
Study of Keynatinib in Patients With Advanced Non-small Cell Lung Cancer With Brain Metastasis or Progression of Brain Metastasis After Treatment With EGFR Inhibitor(s)
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Drug
Study Drug: Keynatinib
Study Phase: Phase 2
View 1 Less Clinical Trial

73 Total Publications

Safety, efficacy, and pharmacokinetics of eratrectinib (VC004) in solid tumors with NTRK fusions: phase 1 results from a phase 1/2 study.
Safety, efficacy, and pharmacokinetics of eratrectinib (VC004) in solid tumors with NTRK fusions: phase 1 results from a phase 1/2 study.
Journal: Experimental hematology & oncology
Published: December 23, 2025

Frequently Asked Questions about Shengyu G. Zhou

Is Shengyu G. Zhou a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Shengyu G. Zhou is classified as an Distinguished expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shengyu G. Zhou participate in research or clinical trials?

Yes. Shengyu G. Zhou has published 73 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Shengyu G. Zhou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhou's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile